Anbio Biotechnology (NASDAQ:NNNN) Trading 8.2% Higher – Here’s What Happened

Shares of Anbio Biotechnology (NASDAQ:NNNN) shot up 8.2% during mid-day trading on Thursday . The stock traded as high as $15.80 and last traded at $16.5070. 20,983 shares changed hands during trading, a decline of 52% from the average daily volume of 43,304 shares. The stock had previously closed at $15.25.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings upgraded Anbio Biotechnology from a “sell (d+)” rating to a “hold (c-)” rating in a report on Thursday, May 14th. One investment analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, the company has a consensus rating of “Hold”.

Anbio Biotechnology Stock Down 9.8%

The business’s 50-day moving average price is $24.89.

Anbio Biotechnology (NASDAQ:NNNN) last announced its earnings results on Tuesday, April 7th. The company reported $0.03 EPS for the quarter.

Anbio Biotechnology Company Profile

Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.